ClinicalTrials.govpublic full text
SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)
cancer, solid tumor, metastatic, melanoma, urothelial, non-small cell lung carcinoma, ccrcc, head and neck squamous cell carcinoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 850530
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.